Aquaphor

DRUG8 trials

Conditions

Atopic DermatitisCancer of the Head and NeckChemical PeelEczemaRadiation DermatitisRadiodermatitisSarcoma, Alveolar Soft PartSkin Diseases

Early Phase 1

Post Treatment Care After Chemical Peel or Laser Resurfacing

WithdrawnNCT01135290

HealthpointChemical Peel

Start: 2010-06-30End: 2010-10-31Updated: 2013-10-01

Phase 1

Topical Use of Difinsa53™ to Prevent Radiation Dermatitis

TerminatedNCT02534129

ProTechSure Scientific, Inc.Radiodermatitis

Start: 2015-08-31End: 2016-03-31Updated: 2017-10-06

Phase 2

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

CompletedNCT01391962

National Cancer Institute (NCI)Sarcoma, Alveolar Soft Part

Start: 2011-07-18End: 2026-01-16Updated: 2026-02-02

Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer

CompletedNCT04865731

The University of Texas Health Science Center at San AntonioCancer of the Head and Neck

Start: 2022-06-15End: 2024-06-18Updated: 2025-08-06

Phase 4

Topical Therapy for Prevention of Infections in Preterm Infants

CompletedNCT00162747

Johns Hopkins Bloomberg School of Public HealthSkin Diseases

Start: 2001-12-31End: 2005-06-30Target: 600Updated: 2005-09-13

Steroid-reducing Effects of Crisaborole

CompletedNCT03832010

Johns Hopkins UniversityAtopic Dermatitis, Eczema

Start: 2019-12-17End: 2024-02-16Updated: 2024-07-19

Unknown Phase

StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis

TerminatedNCT05553392

Stratpharma AGRadiation Dermatitis

Start: 2022-11-01End: 2024-05-30Updated: 2024-09-04

Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis

CompletedNCT05810194

Stratpharma AGRadiation Dermatitis

Start: 2023-05-01End: 2023-12-31Updated: 2024-02-01

Related Papers

Abstract CT168: Randomized phase 2 trial of sunitinib or cediranib in alveolar soft part sarcoma

Cancer Research2022-06-15

Impact of emollient therapy for preterm infants in the neonatal period on child neurodevelopment in Bangladesh: an observational cohort study.

2021-05-266 citations

Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.

2019-05-3166 citations